Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

State of the union between metabolism and the immune system in type 2 diabetes

Producción científica: Review articlerevisión exhaustiva

135 Citas (Scopus)

Resumen

Lymphocytes and myeloid cells (monocyte/macrophages) have important roles in multiple types of diseases characterized by unresolved inflammation. The relatively recent appreciation of obesity, insulin resistance and type 2 diabetes (T2D) as chronic inflammatory diseases has stimulated interest in understanding the role of immune cells in metabolic imbalance. Myeloid cells regulate inflammation through cytokine production and the adipose tissue remodeling that accompanies hyper-nutrition, thus are critical players in metabolic homeostasis. More recently, multiple studies have indicated a role for T cells in obesity-associated inflammation and insulin resistance in model organisms, with parallel work indicating that pro-inflammatory changes in T cells also associate with human T2D. Furthermore, the expansion of T cells with similar antigen-binding sites in obesity and T2D indicates these diseases share characteristics previously attributed to inflammatory autoimmune disorders. Parallel pro-inflammatory changes in the B-cell compartment of T2D patients have also been identified. Taken together, these studies indicate that in addition to accepted pro-inflammatory roles of myeloid cells in T2D, pro-inflammatory skewing of both major lymphocyte subsets has an important role in T2D disease pathogenesis. Basic immunological principles suggest that alterations in lymphocyte function in obesity and T2D patients are an integral part of a feed-forward pro-inflammatory loop involving additional cell types. Importantly, the pro-inflammatory loop almost inevitably includes adipocytes, known to respond to pro-inflammatory, pro-diabetogenic cytokines originating from the myeloid and lymphoid compartments. We propose a model for inflammation in T2D that functionally links lymphocyte, myeloid and adipocyte contributions, and importantly proposes that tools for B-cell ablation or regulation of T-cell subset balance may have a place in the endocrinologist's limited arsenal.

Idioma originalEnglish
Páginas (desde-hasta)239-250
Número de páginas12
PublicaciónGenes and Immunity
Volumen12
N.º4
DOI
EstadoPublished - jun 2011

Nota bibliográfica

Funding Information:
This work was supported by NIH R01 AI54611, NIH R21 DK089270 and a Research Grant from the American Diabetes Association. The authors thank Susan Fried, Gerald Denis, Jongsoon Lee, Marty Obin, and Marie McDonnell for valuable conversations related to this work.

Financiación

This work was supported by NIH R01 AI54611, NIH R21 DK089270 and a Research Grant from the American Diabetes Association. The authors thank Susan Fried, Gerald Denis, Jongsoon Lee, Marty Obin, and Marie McDonnell for valuable conversations related to this work.

FinanciadoresNúmero del financiador
National Institutes of Health (NIH)R21 DK089270, R01 AI54611
American Diabetes Association Inc
National Institute of Dental and Craniofacial ResearchR21DE021154

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Immunology
    • Genetics
    • Genetics(clinical)

    Huella

    Profundice en los temas de investigación de 'State of the union between metabolism and the immune system in type 2 diabetes'. En conjunto forman una huella única.

    Citar esto